GT Healthcare Capital Partners
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
GT Healthcare Capital Partners specializes in healthcare investments around the globe that aim to change technology landscapes.
Investor Profile
GT Healthcare Capital Partners has made 19 investments, with 1 in the past 12 months and 11% as lead.
Stage Focus
- Series C (26%)
- Series A (26%)
- Series B (16%)
- Series Unknown (11%)
- Seed (11%)
- Series D (5%)
- Private Equity (5%)
Country Focus
- United Kingdom (53%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- United States (37%)
- France (11%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Artificial Intelligence (Ai)
- Medical
- Pharmaceutical
- Medical Device
- Oncology
- Nanotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
